Known targets — ChEMBL curated mechanism
MMP1MMP13MMP7MMP8polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Ether. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 4/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ether SCHEMBL4459840 | 0.90 | LMNA (0.39) | ALDH1A1TSHRLMNA | |
| Ether SCHEMBL254669 | 0.88 | TSHR (0.44) | ALDH1A1TSHRLMNAHSD17B10TDP1 | |
| Ether SCHEMBL6209863 | 0.84 | ALDH1A1 (0.45) | ALDH1A1TSHRLMNAHSD17B10TDP1 | |
| Alcohol SCHEMBL496231 | 0.83 | — | — | |
| Ether SCHEMBL5693230 | 0.83 | ALDH1A1 (0.56) | ALDH1A1TSHRLMNAHSD17B10 | |
| Ether SCHEMBL6581224 | 0.83 | ALDH1A1 (0.56) | ALDH1A1TSHRLMNAHSD17B10 | |
| Ether SCHEMBL5597265 | 0.83 | ALDH1A1 (0.56) | ALDH1A1TSHRLMNAHSD17B10 | |
| Ether SCHEMBL2801167 | 0.83 | ALDH1A1 (0.56) | ALDH1A1TSHRLMNAHSD17B10 | |
| Ether SCHEMBL9058622 | 0.83 | ALDH1A1 (0.56) | ALDH1A1TSHRLMNAHSD17B10 | |
| Ether SCHEMBL9688867 | 0.83 | ALDH1A1 (0.56) | ALDH1A1TSHRLMNAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11322711-B2 | Organic EL light emitting apparatus and electronic instrument | IDEMITSU KOSAN CO., LTD. (JP) | 2022-05-03 | — | — | US | disclosed |
| US-20210043866-A1 | ORGANIC EL LIGHT EMITTING APPARATUS AND ELECTRONIC INSTRUMENT | IDEMITSU KOSAN CO., LTD. (JP) | 2021-02-11 | — | — | US | disclosed |
| US-9923151-B2 | Material for organic electroluminescent elements, and organic electroluminescent element using same | IDEMITSU KOSAN CO., LTD. (JP) | 2018-03-20 | — | — | US | disclosed |
| US-20150287931-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT | IDEMITSU KOSAN CO., LTD. (JP) | 2015-10-08 | — | — | US | disclosed |
| US-20140110692-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | IDEMITSU KOSAN CO., LTD. (JP) | 2014-04-24 | — | — | US | disclosed |
| US-20130270540-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2013-10-17 | — | — | US | disclosed |
| US-20070296328-A1 | Organic Electroluminescent Device | IDEMITSU KOSAN CO., LTD. (JP) | 2007-12-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150287931-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT | DDT, DDC, TYR | ALDH1A1 254/4885TSHR 4223/4885LMNA 2139/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.